Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis
Iles, Ray K. (2007) Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Molecular and cellular endocrinology, 260-26 . pp. 264-270. ISSN 0303-7207
Full text is not in this repository.
Ectopic expression of the β-subunit of human chorionic gonadotropin (hCG) is now a recognized phenomenon in 20–40% of all common epithelial carcinoma arising from mucosal epithelia such as bladder, cervix, lung and naso-pharynx. Recent studies have shown that it acts as an autocrine growth factor by inhibiting apoptosis. Structural homology and in vitro studies suggest that it may achieve this by inhibition of the transforming growth factor β (TGFβ) receptor complex. Such a molecular mechanism would go some way to explaining ectopic hCGβ's association with poor prognosis and tumors that will rapidly progress to metastasis.
|Research Areas:||A. > School of Science and Technology > Natural Sciences|
|Depositing User:||Users 36 not found.|
|Date Deposited:||20 May 2009 09:15|
|Last Modified:||11 Dec 2015 16:03|
Actions (login required)